Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04046263 · ClinicalTrials.gov registry record · Phase 4
Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients
A Phase 4 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT04046263 is a Phase 4 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 17 participants.
The verdict
NCT04046263, a Phase 4 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
Prospective pilot study to determine if changing the phosphate binder to sucroferric oxyhydroxide for for 6 months improves disordered mineral metabolism and nutrition status in peritoneal dialysis patients.
Interventions
- DRUG Sucroferric Oxyhydroxide Chewable Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2021-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04046263
The ClinicalTrials.gov registry entry for NCT04046263 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sucroferric Oxyhydroxide Chewable Tablet is the first listed.
NCT04046263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04046263 about?
NCT04046263 is a clinical study titled "Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients". Prospective pilot study to determine if changing the phosphate binder to sucroferric oxyhydroxide for for 6 months improves disordered mineral metabolism and nutrition status in peritoneal dialysis patients.
What is the current status of trial NCT04046263?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2020-02-01. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT04046263?
The interventions under investigation include: Sucroferric Oxyhydroxide Chewable Tablet (DRUG).
Who is sponsoring clinical trial NCT04046263?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.